SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-004872
Filing Date
2017-03-21
Accepted
2017-03-21 14:00:31
Documents
43
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crxm-10q_20160930.htm 10-Q 875445
2 EX-31.1 crxm-ex311_8.htm EX-31.1 10175
3 EX-31.2 crxm-ex312_7.htm EX-31.2 10177
4 EX-32 crxm-ex32_6.htm EX-32 5503
  Complete submission text file 0001564590-17-004872.txt   3081355

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crxm-20160930.xml EX-101.INS 491450
6 XBRL TAXONOMY EXTENSION SCHEMA crxm-20160930.xsd EX-101.SCH 31262
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxm-20160930_cal.xml EX-101.CAL 24194
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxm-20160930_def.xml EX-101.DEF 93384
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxm-20160930_lab.xml EX-101.LAB 233672
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxm-20160930_pre.xml EX-101.PRE 172975
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 17703778
SIC: 2836 Biological Products, (No Diagnostic Substances)